This website is intended for healthcare professionals only

Trending Topic

Acute myeloid leukaemia
3 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

“We are facing an exciting era of fast-paced drug development in acute myeloid leukaemia” writes Gianfranco Bittar and colleagues at Baylor College of Medicine, Houston, TX, USA, in a review published in touchREVIEWS in Oncology & Haematology. In 2020, there were an estimated 21,450 new patients with acute myeloid leukaemia (AML) and 11,180 AML-related deaths […]

World Orphan Drug Congress Europe (WODC)

World Orphan Drug Congress Europe (WODC)
Web Address: WODC Website

Now in its 17th edition, the World Orphan Drug Congress Europe returns to Amsterdam as the largest and most established event globally for orphan drugs and rare diseases. This flagship event continues to bring together the leading minds and most influential stakeholders driving progress in rare disease treatment.

Join 1,800+ attendees, gain insights from 250+ industry-leading speakers, and connect with 100+ exhibitors as we explore the entire orphan drug lifecycle—from regulatory and policy developments to global pricing, market access, clinical innovation, and breakthrough gene therapies.

Our audience includes senior leaders across R&D, gene therapy, rare disease strategy, precision and personalised medicine, genetic research, patient advocacy, ATMPs, investment, regulatory affairs, government agencies, and more.

Be part of the industry’s most established and impactful rare disease event.

Register now and use code THA20 for an exclusive 20% discount.

🗓️26th October 2026 | Pre-Congress Workshops

🗓️27th – 28th October 2026 | Main Congress Days

📍RAI Convention Centre, Amsterdam, Netherlands

Follow #WODC on social media to stay up to date 👇

LinkedIn: https://www.linkedin.com/company/world-orphan-drug-congress-europe/
Twitter: https://twitter.com/orphan_drugs

Further Resources

Close Popup